• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓弹力图引导下评估失代偿期肝硬化患者的凝血功能以指导血液成分输血

Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions.

作者信息

Romašovs Andris, Stāka Aiga, Ivanova Jelena, Puķītis Aldis

机构信息

Pauls Stradins Clinical University Hospital, Latvia.

University of Latvia, Latvia.

出版信息

Clin Exp Hepatol. 2025 Jun;11(2):147-151. doi: 10.5114/ceh.2025.151768. Epub 2025 Jun 26.

DOI:10.5114/ceh.2025.151768
PMID:40904665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12403705/
Abstract

AIM OF THE STUDY

The primary objective of this study was to assess the impact of thromboelastography (TEG) on the decision-making process of gastroenterologists and hepatologists regarding blood component (BC) transfusions in patients with decompensated cirrhosis before invasive manipulations.

MATERIAL AND METHODS

This study was a prospective, single-center, randomized controlled trial. Throughout the trial, the decision-making process was not actively influenced. However, TEG results were made available to the physicians, offering recommendations regarding the need for specific BC transfusions. To assess whether the availability of TEG data influences clinical decision-making, a subsequent statistical analysis was conducted.

RESULTS

After application of exclusion criteria, 20 patients were enrolled in the study. The results showed that in the TEG group, the need for BC transfusions was 20% lower than in the control group, although this difference was not statistically significant ( = 0.384). When hypothesizing that all patients in the TEG group would have received BC transfusions prior to the procedure, TEG was estimated to reduce transfusion requirements by 69.2%. However, this reduction was also not statistically significant ( > 0.05).

CONCLUSIONS

In settings where nearly all physicians were familiar with the concept of hemostatic changes in liver cirrhosis, TEG was estimated to reduce transfusion requirements by 20%.

摘要

研究目的

本研究的主要目的是评估血栓弹力图(TEG)对胃肠病学家和肝病学家在失代偿期肝硬化患者进行侵入性操作前关于血液成分(BC)输血决策过程的影响。

材料与方法

本研究是一项前瞻性、单中心、随机对照试验。在整个试验过程中,决策过程未受到积极影响。然而,TEG结果会提供给医生,并就特定BC输血的必要性给出建议。为评估TEG数据的可用性是否会影响临床决策,随后进行了统计分析。

结果

应用排除标准后,20名患者纳入研究。结果显示,在TEG组中,BC输血的需求比对照组低20%,尽管这一差异无统计学意义( = 0.384)。假设TEG组所有患者在手术前都接受了BC输血,估计TEG可使输血需求减少69.2%。然而,这一减少也无统计学意义( > 0.05)。

结论

在几乎所有医生都熟悉肝硬化止血变化概念的情况下,估计TEG可使输血需求减少20%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf62/12403705/1623f97728c9/CEH-11-56194-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf62/12403705/1623f97728c9/CEH-11-56194-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf62/12403705/1623f97728c9/CEH-11-56194-g001.jpg

相似文献

1
Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions.血栓弹力图引导下评估失代偿期肝硬化患者的凝血功能以指导血液成分输血
Clin Exp Hepatol. 2025 Jun;11(2):147-151. doi: 10.5114/ceh.2025.151768. Epub 2025 Jun 26.
2
Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.采用血栓弹力图(TEG)或血栓弹力测定法(ROTEM)监测成人或儿童出血患者的止血治疗效果并与常规治疗进行比较。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD007871. doi: 10.1002/14651858.CD007871.pub3.
3
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
4
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
5
Thromboelastography-Guided versus Standard-of-Care or On-Demand Platelet Transfusion in Patients with Cirrhosis and Thrombocytopenia Undergoing Procedures: A Randomized Controlled Trial.血栓弹力描记术指导与标准治疗或按需血小板输注治疗肝硬化伴血小板减少症患者行介入治疗:一项随机对照试验。
J Vasc Interv Radiol. 2024 Oct;35(10):1508-1518.e2. doi: 10.1016/j.jvir.2024.06.014. Epub 2024 Jun 25.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding.用于成年创伤出血患者创伤性凝血病的血栓弹力图(TEG)和旋转血栓弹力测定法(ROTEM)
Cochrane Database Syst Rev. 2015 Feb 16;2015(2):CD010438. doi: 10.1002/14651858.CD010438.pub2.
8
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.一种仅用于治疗与预防性血小板输注策略,用于预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后出血。
Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD010981. doi: 10.1002/14651858.CD010981.pub2.
9
Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis.用于辅助止血诊断、管理和监测的即时粘弹性检测:系统评价与成本效益分析
Health Technol Assess. 2015 Jul;19(58):1-228, v-vi. doi: 10.3310/hta19580.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Guidelines for the management of coagulation disorders in patients with cirrhosis.肝硬化患者凝血障碍管理指南。
Rev Gastroenterol Mex (Engl Ed). 2024 Jan-Mar;89(1):144-162. doi: 10.1016/j.rgmxen.2023.08.008. Epub 2024 Apr 9.
2
Expert opinion on bleeding risk from invasive procedures in cirrhosis.肝硬化患者侵入性操作出血风险的专家意见。
JHEP Rep. 2023 Dec 19;6(3):100986. doi: 10.1016/j.jhepr.2023.100986. eCollection 2024 Mar.
3
Coagulopathy of liver disease-a pathophysiologic rebalance of hemostasis and thrombosis.
肝病凝血功能障碍——止血与血栓形成的病理生理再平衡
J Thromb Haemost. 2023 Aug;21(8):2045-2047. doi: 10.1016/j.jtha.2023.05.006.
4
AGA Clinical Practice Update: Coagulation in Cirrhosis.AGA 临床实践更新:肝硬化中的凝血。
Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12.
5
Algorithms for managing coagulation disorders in liver disease.肝病凝血障碍的管理算法。
Hepatol Int. 2018 Sep;12(5):390-401. doi: 10.1007/s12072-018-9886-6. Epub 2018 Jul 31.
6
Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey.西班牙肝硬化患者止血功能改变及其相关疾病的管理:一项全国性调查。
Dig Liver Dis. 2019 Jan;51(1):95-103. doi: 10.1016/j.dld.2018.06.003. Epub 2018 Jun 12.
7
Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis.肝硬化患者凝血功能障碍与侵入性操作后出血风险的相关性
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):220-227. doi: 10.4103/sjg.SJG_486_17.
8
Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.侵入性操作后出血在血小板减少的肝硬化患者中很少见,且无法通过血小板计数预测。
Eur J Intern Med. 2017 Mar;38:79-82. doi: 10.1016/j.ejim.2016.11.007. Epub 2016 Dec 15.
9
Coagulopathy in liver disease: a balancing act.肝病中的凝血功能障碍:一种平衡行为。
Hematology Am Soc Hematol Educ Program. 2015;2015:243-9. doi: 10.1182/asheducation-2015.1.243.
10
Patterns of blood component use in cirrhosis: a nationwide study.肝硬化血液成分使用模式:一项全国性研究。
Liver Int. 2016 Apr;36(4):522-9. doi: 10.1111/liv.12999. Epub 2015 Nov 26.